Fluorocarbons and fluorosurfactants for in vivo oxygen transport (blood substitutes), imaging, and drug delivery

MRS Bulletin

Volumn 24, Issue 5, 1999, Pages 42-48

  Riess, Jean G ^a,b   Krafft, Marie Pierre ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Alliance Pharmaceutical Corp   (France)

^c INSTITUT CHARLES SADRON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLOIDS; CONTRAST MEDIA; CONTROLLED DRUG DELIVERY; EMULSIONS; FLUOROCARBONS; LIPIDS; NANOSTRUCTURED MATERIALS; OXYGEN; SURFACE ACTIVE AGENTS; ULTRASONIC IMAGING;

AMPHIPHILES; FLUOROSURFACTANTS;

BIOMATERIALS;

EID: 0032658367     PISSN: 08837694     EISSN: None     Source Type: Journal    
DOI: 10.1557/S0883769400052313     Document Type: Article

References (83)

1. J.G. Riess, Coll. Surf. 84 (1994) p. 33.
2. M.P. Krafft and J.G. Riess, Biochimie 80 (1998) p. 489.
3. M.P. Krafft, J.G. Riess, and J.G. Weers, "The Design and Engineering of Oxygen-Delivering Fluorocarbon Emulsions," in Submicronic Emulsions in Drug Targeting and Delivery, edited by S. Benita (Harwood Academic Publ., Amsterdam, 1998) p. 235.
4. R.E. Banks, B.E. Smart, and J.C. Tatlow, Organofluorine Chemistry, Principles and Commercial Applications (Plenum Press, New York, 1994).
5. T.H. Shaffer, M.R. Wolfson, J.S. Greenspan, S.D. Rubenstein, and R.G. Stern, Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 315.
6. C.L. Leach, J.S. Greenspan, D. Rubenstein, T.H. Shaffer, M.R. Wolfson, J.C. Jackson, R. DeLemos, and B.P. Fuhrman, New Engl. J. Med. 335 (1996) p. 761.
7. C.M. Weis, M.R. Wolfson, and T.H. Shaffer, Ann. Med. 29 (1997) p. 509.
8. S. Chang and J.K. Sun, "Perfluorocarbon Liquids in Vitreoretinal Surgery," in Fluorine in Medicine in the 21st Century (Rapra Technology, Manchester, UK, 1994).
9. P. Anthony, K.C. Lowe, M.R. Davey, and J.B. Power, Biotechnol. Tech. 9 (1995) p. 777.
10. S.F. Flaim and J.G. Riess, U.S. Patent No. 5,726,209 (1998).
11. E. Kissa, Fluorinated Surfactants, Synthesis, Properties, Applications (Marcel Dekker, New York, 1994).
12. J. Greiner, J.G. Riess, and P. Vierling, "Fluorinated Surfactants Intended for Biomedical Uses," in Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications, edited by R. Filler, Y. Kobayashi, and L. Yagupolski (Elsevier Science, New York, 1993) p. 339.
13. J.G. Riess and M.P. Krafft, Biomaterials 19 (1998) p. 1529.
14. V.M. Sadtler, F. Giulieri, M.P. Krafft, and J.G. Riess, Chem. Eur. J. 10 (1998) p. 1952.
15. J.G. Riess, C. Arlen, J. Greiner, M. Le Blanc, A. Manfredi, S. Pace, C. Varescon, and L. Zarif, "Design, Synthesis and Evaluation of Fluorocarbons and Surfactants for In-Vivo Applications: New Perfluoroalkylated Surfactants," in Blood Substitutes, edited by T.M.S. Chang and R.P. Geyer (Marcel Dekker, New York, 1989) p. 421.
16. A.A. Pavia, B. Pucci, L. Zarif, and J.G. Riess, Proc. Int. Symp. Control. Rel. Bioact. Mater. 21 (1994) p. 87.
17. J.G. Riess, J. Liposome Res. 5 (1995) p. 413.
18. J.G. Riess, S. Pace, and L. Zarif, Adv. Mater. 3 (1991) p. 249.
19. J.G. Riess, J. Drug Targeting 2 (1994) p. 455.
20. C. Der Mardirossian, M.P. Krafft, T. Gulik-Krzywicki, M. Le Maire, and F. Lederer, Biochimie 80 (1998) p. 531.
21. D.M. Worah, D.R. Kessler, A.R. Meuter, M. Huang, J-M. Correas, and S.C. Quay, Drug Future 22 (1997) p. 378.
22. J.C. Maurizis, M. Azim, M. Rapp, B. Pucci, A. Pavia, J.C Madelmont, and A. Veyre, Xenobiotica 24 (1994) p. 535.
23. G.L. Gaines, Langmuir 7 (1991) p. 3054.
24. M.P. Turberg and J.E. Brady, J. Am. Chem. Soc. 110 (1988) p. 7797.
25. R.J. Twieg, T.P. Russell, R.L. Siemens, and J.F. Rabolt, Macromolecules 18 (1985) p. 1361.
26. T.P. Russell, J.F. Rabolt, R.T. Twieg, R.L. Siemens, and B.L. Farmer, ibid. 19 (1986) p. 1135.
27. J.G. Riess, L. Solé-Violan, and M. Postel, J. Dispersion. Sci. Technol. 13 (1992) p. 349.
28. J.G. Riess, C. Cornélus, R. Follana, M.P. Krafft, A.M. Mahé, M. Postel, and L. Zarif, Adv. Exp. Med. Biol. 345 (1994) p. 227.
29. L. Trevino, F. Frézard, J.P. Rolland, M. Postel, and J.G. Riess, Coll. Surf. 88 (1994) p. 223.
30. M.P. Krafft and Y. Ferro, Polym. Preprints 39 (1998) p. 938.
31. N. Privitera, R. Naon, and J.G. Riess, Biochim. Biophys. Acta 1254 (1995) p. 1.
32. M.P. Krafft, V.M. Sadtler, and J.G. Riess, "Multiple Emulsions with a Fluorocarbon Continuous Phase," in Intl. Symp. on Fluorine Chemistry (Vancouver, 1997).
33. N.O. Brace, J. Org. Chem. 38 (1973) p. 3167.
34. J.F. Rabolt, T.P. Russel, and R.T. Twieg, Macromolecules 17 (1984) p. 2786.
35. L. Zarif, M. Postel, B. Septe, L. Trevino, J.G. Riess, A-M. Mahé, and R. Follana, Pharm. Res. 11 (1994) p. 122.
36. R. Elbert, T. Folda, and H. Ringsdorf, J. Am. Chem. Soc. 106 (1984) p. 7687.
37. T. Kunitake, Angew. Chem., Int. Ed. Engl. 31 (1992) p. 709.
38. J.G. Riess, F. Frézard, J. Greiner, M.P. Krafft, C. Santaella, P. Vierling, and L. Zarif, "Membranes, Vesicles, and other Supramolecular Systems Made from Fluorinated Amphiphiles," in Handbook of Nonmedical Applications of Liposomes, edited by Y. Barenholz and D.D. Lasic (CRC Press, Boca Raton, 1996) p. 97.
39. J.G. Riess, New J. Chem. 19 (1995) p. 891.
40. J.G. Riess and M.P. Krafft, Chem. Phys. Lipids 75 (1995) p. 1.
41. M.P. Krafft, F. Giulieri, and J.G. Riess, Angew. Chem., Int. Ed. Engl. 32 (1993) p. 741.
42. F. Frézard, C. Santaella, P. Vierling, and J.G. Riess, Biochim. Biophys. Acta 1192 (1994) p. 61.
43. C. Santaella, F. Frézard, P. Vierling, and J.G. Riess, FEBS Lett. 336 (1993) p. 481.
44. F. Giulieri, M.P. Krafft, and J.G. Riess, Angew. Chem., Int. Ed. Engl. 33 (1994) p. 1514.
45. F. Giulieri, F. Guillod, J. Greiner, M. Krafft, and J.G. Riess, Chem. Eur. J. 2 (1996) p. 1335.
46. T. Imae, M.P. Krafft, F. Giulieri, T. Matsumoto, and T. Tada, Prog. Coll. Polym. Sci. 106 (1997) p. 52.
47. T. Imae, K. Funayama, M.P. Krafft, F. Giulieri, T. Tada, and M. Matsumoto, J. Coll. I. Sci. 212 (1999).
48. J. Fuhrhop and W. Helfrich, Chem. Rev. 93 (1993) p. 1565.
49. J.M. Schnur, Science 262 (1993) p. 1669.
50. T.M.S. Chang, J.G. Riess, and R.M. Winslow, eds., Blood Substitutes, General, Proc. 5th Int. Symp. on Blood Substitutes, vol. 1; Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 945.
51. T.M.S. Chang, J.G. Riess, and R.M. Winslow, eds., Blood Substitutes, General, Proc. 5th Int. Symp. on Blood Substitutes, vol. 1; Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 945.
52. J.G. Riess, ed., Blood Substitutes, the Fluorocarbon Approach, Proc. 5th Int. Symp, on Blood Substitutes, vol. 3; Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 945.
53. J.G. Riess, ed., Blood Substitutes, the Fluorocarbon Approach, Proc. 5th Int. Symp, on Blood Substitutes, vol. 3; Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 945.
54. N.S. Faithfull, "The Role of Perfluorochemicalsin Surgery and the ITU," in Yearbook of Intensive Care and Emergency Medicine, edited by J.L. Vincent (Springer-Verlag, Brussels, 1994) p. 237.
55. J.G. Riess, "Fluorocarbon-based Oxygen Delivery: Basic Principles and Product Development," in Blood Substitutes: Methods, Products and Clinical Trials, edited by T.M.S. Chang (Karger Landes Systems, New York, 1998) p. 101.
56. J.G. Weers, J. Liu, T. Fields, P. Resch, J. Cavin, and R.A. Arlauskas, Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 1175.
57. J.A. Wahr, A. Trouwborst, R.K. Spence, C.P. Henny, A.C. Cernaianu, G.P. Graziano, K.K. Tremper, K.E. Flaim, P.E. Keipert, N.S. Faithfull, and J.J. Clymer, Anesth. Analg. 82 (1996) p. 103.
58. J.G. Riess and P.E. Keipert, "Update on Perfluorocarbon-based Oxygen Delivery Systems," in Blood Substitutes - Present and Future Perspectives, Chapter 7, edited by E. Tsuchida (Elsevier Science, Amsterdam, 1998) p. 91.
59. T. Monk, R. Winston, J. Wahr, D. Frei, J. Wang, and P. Keipert, Anesth. Analg. 86 (1998) p. S142.
60. P.E. Keipert, N.S. Faithfull, D.J. Roth, J.D. Bradley, S. Batra, P. Jochelson, and K.E. Flaim, Adv. Exp. Med. Biol. 388 (1996) p. 603.
61. T.F. Zuck and J.G. Riess, Crit. Rev. Clin. Lab. Sci. 31 (1994) p. 295.
62. D.W. Amory, B. Leone, N.D. Croughwell, W.D. White, K.M.B. Richardson, C.F. Osgood, L. Gerstle, and M.F. Newman, Anesth. Analg. 86 (1998).
63. A. Lattes and I. Rico-Lattes, Art. Cells, Blood Subst., Immob. Biotech. 22 (1994) p. 1007.
64. K-V. Schubert and E.W. Kaler, Coll. Surf. 84 (1994) p. 97.
65. G. Mathis, P. Leempoel, J.C. Ravey, C. Selve, and J.J. Delpuech, J. Am. Chem. Soc. 106 (1984) p. 6162.
66. F. Forsberg and B.B. Goldberg, Sci. Med. May/June (1998) p. 54.
67. H.C. Dittrich, "Safety of Albumin Shell Microspheres Albunex and Optison," in Proc. Ultrasound Contrast Research Symp. (San Diego, 1998).
68. E.G. Schutt, T.J. Pelura, and R.M. Hopkins, Acad. Radiol. 35 (1996) p. 188.
69. J.L. Cohen, J. Cheirif, D.S. Segar, L.D. Gillam, J.S. Gottdiener, E. Hausnerova, and D.E. Bruns, J. Am. Coll. Cardiol. 32 (1998) p. 746.
70. V.M. Sadtler, M.P. Krafft, and J.G. Riess, Angew. Chem., Int. Ed. Engl. 35 (1996) p. 1976.
71. Ibid., "Reverse Water-in-Fluorocarbon Emulsions as a Drug Delivery System: An In Vitro Study," in Proc. 2nd World Congress on Emulsion (Bordeaux, 1997).
72. L.A. Trevino, L.A. Dellamary, T.E. Tarara, J.G. Weers, and H.M. Ranney, U.S. Patent No. 5,667,809 (1997).
73. K.A. Johnson, U.S. Patent No. 5,126,123 (1992).
74. A. Kabalnov, T. Tarara, J.G. Weers, E. Schutt, and J.G. Riess, U.S. Patent Application No. 60,060,337 (1997).
75. M.P. Krafft, "Fluorocarbon Gels," in Novel Cosmetic Delivery Systems, edited by S. Magdassi and E. Touitou (Marcel Dekker, New York, 1998) p. 195.
76. J.C. Ravey and M. Stebe, Prog. Coll. Polym. Sci. 82 (1990) p. 218.
77. M.P. Krafft and J.G. Riess, Angew. Chem. Int., Ed. Engl. 33 (1994) p. 1100.
78. Ibid., French Patent No. 2,737,135 (1995).
79. S.W. Barton, A. Goudot, O. Bouloussa, F. Rondelez, B. Lin, F. Novak, A. Acero, and S.A. Rice, J. Chem. Phys. 96 (1992) p. 1343.
80. M. Goldmann, P. Nassoy, and F. Rondelez, Physica A 200 (1993) p. 688.
81. F. Jeanneaux, F. Giulieri, M.P. Krafft, and M. Goldmann (in preparation).
82. M.P. Krafft, Q. Huo, S. Vidon, R. Leblanc, and F. Giulieri, presented at American Chemical Society Meeting, Boston, 1998.
83. M.P. Krafft and J. Cohen (in preparation).